Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)
NCT02096068
Confusion, Delirium
Berlin, Germany
View Trial DetailsNCT Number: NCT03540433
The purpose of this international, multi-centre observational study is to describe perioperative cognitive changes (pre-existing neurocognitive disorder [NCD], postoperative delirium [POD] and Postoperative Cognitive Dysfunction [POCD]) up to five years after elective surgery in a mixed cohort. Measurements and definitions of cognitive outcomes will be based on current consensus and used for further harmonization in future clinical studies on perioperative cognitive trajectories. This is a feasibility approach to identify an effective screening procedure and estimate loss to follow up rates for the planning of future intervention studies. Data from this trial may also serve to facilitate and implement time effective cognitive screening and risk stratification concerning postoperative cognitive decline in the anaesthesiological preoperative assessment.
Looking for future studies?
Notify Me70 year and older
All sexes
Observational
Arbeitsbereich Physikalische Medizin, Berlin, Germany
This international observational study on perioperative cognitive trajectories (POCD census international/PCI) has been designed as a pilot study to allow a peer reviewed process of four international test centres on measurement of perioperative acute and long-term cognitive outcome. Data from standard clinical treatment of 500 patients age ≥ 70 years scheduled for elective surgery (stratified according to preoperative assessment of frailty and monitored by intraoperative depth of anaesthesia) will be supplemented by guideline conform delirium- analgesia- and sedation screening until day 5 after surgery, I-Pad based neuropsychological testing [Cambridge Neuropsychological Test Automated Battery - CANTAB connect] pre-operatively, 3 months, 1- 2- and 5 years after surgery, a paper-based verbal fluency test (animal naming test from Addenbrooke's Cognitive Examination Revised (ACE-R)), a paper based test on executive function (Trailmaking Test), cognitive screening tests (Montreal Cognitive Assessment (MOCA) and Mini-Cog), and concomitant questionnaires to assess functional status, self- and by proxy rating of cognitive performance, psychological factors (depression, perioperative anxiety, stress, resilience and coping), social support, perioperative anxiety, stress, resilience and coping, as well as risk consumption of alcohol and tobacco.
A non-surgical control group of 100 study participants who are not scheduled for surgery will be followed up at the same time points as the surgical cohort for scaling of cognitive data and definition of cut off values to define significant cognitive decline.
Secondary outcome measures of this trial comprise levels and changes in molecular biomarkers involved in Alzheimer's dementia etiology sampled from spinal fluid on induction of spinal anaesthesia and sampled from blood in all patients.
Retrospective comparison collective (01/01/2017 to 01/01/2022):
A group of around 8000 surgical patients aged 65 and older at the Charité will be examined as control group. This control group is required for various questions, especially influencing factors with regard to the postoperative outcome of delirium, and aims to test the predictive ability of clinical routine data with regard to postoperative delirium. As part of the multimodality of this retrospective comparative cohort study, in cooperation with PD. Dr Scheel and in collaboration with Prof. Dr. Finke, cranial MRI scans analyzing routine data from the Institute of Neuroradiology. The subject of the investigation is initially the entire electronic routine data of the control group, including the existing cranial MRI scans.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 1 year
Neuropsychological testing
Time frame: Up to 5 years
Neuropsychological testing
Time frame: Up to 5 years
Short neuropsychological testing
Time frame: Up to five years
Definition according to DSM-V as proposed in Evered L et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery. Br J Anaesth, Anesthesiology, Can J Anesth, Anesth Analg, J Alz Dis, acta scandinavica anaesthesiologica (Joint Publication) 2017; Accepted, In Press. We will use an I-pad based neuropsychological test battery (CANTAB connect), and cognitive screening instruments (MOCA, Mini-Cog™ and Animal naming test on verbal fluency from ACE-R) for assessment of cognitive function, MMQ and IQ-code for self- or by proxy reported cognitive concern and ADL/IADL for assessment of functional status. Mild/major Neurocognitive Disorder measured at baseline (pre-existing NCD) 3 months and 1 year (with specifier 'POCD'), 2- and 5 years after surgery
Time frame: Up to five years
Definition according to DSM-V as proposed in Evered L et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery. Br J Anaesth, Anesthesiology, Can J Anesth, Anesth Analg, J Alz Dis, acta scandinavica anaesthesiologica (Joint Publication) 2017; Accepted, In Press. We will use an I-pad based neuropsychological test battery (CANTAB connect), and cognitive screening instruments (MOCA, Mini-Cog™ and Animal naming test on verbal fluency from ACE-R) for assessment of cognitive function, MMQ and IQ-code for self- or by proxy reported cognitive concern and ADL/IADL for assessment of functional status. Mild/major Neurocognitive Disorder measured at baseline (pre-existing NCD) 3 months and 1 year (with specifier 'POCD'), 2- and 5 years after surgery
Time frame: Up to five years
Patients for spinal anesthesia who consented on lumbar puncture receive biomarkers analysis from spinal fluid (beta Amyloid 1-40, beta-Amyloid 1-42, beta-Amyloid Ratio (42/40*10), phospho-TAU, Protein 14-3-3, PRPSc, TAU (Gesamt-Tau)).
Time frame: Up to five years
Patients consented on blood sampling receive biomarker analysis from blood (Apolipoprotein E).
Time frame: Up to five years
Time frame: Up to five years
Comorbidities will be quantified by use of Charlson Comorbidity index
Time frame: Up to five years
Changes in the nutritional status after elective surgery are measured by a questionnaire.
Time frame: Up to five years
Malnutrition is measured by the Body mass index
Time frame: Up to five years
Malnutrition is measured by weight
Time frame: Up to five years
Malnutrition is measured by weight
Time frame: Up to five years
The dental status is determined by tooth doctors
Time frame: Up to five years
The composite outcome measure "Sarcopenia" is defined by the following three criteria: 1) low muscle strength (hand grip strength), 2) low muscle quantity (calf circumference and 3) low physical performance (gait speed). Criterion (1) identifies probable sarcopenia, additional documentation of criterion (2) confirms sarcopenia diagnosis, and if all criteria (1), (2) and (3) are met, sarcopenia is considered severe.
Time frame: Up to five years
Calf circumference is measured in a standardized position and documented in centimeter.
Time frame: Up to five years
Arm circumference is measured in a standardized position and documented in centimeter.
Time frame: Up to five years
Adherence to Mediterranean diet (MD) is measured with a German Mediscore, could range from 0 to 9, with higher scores (6-9) indicating greater MD adherence.
Time frame: Up to five years
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Time frame: At the beginning of the observation
Physical activity is evaluated by interviewing the Patient.
Time frame: Participants will be followed up during surgery, an estimated duration of 1 hour
Surgical risk will be described by type and length of surgery and perioperative cardiac risk estimation as described in Anästh Intensivmed 2017; 58:349-364.
Time frame: At the beginning of the observation
Anaesthesiological risk will be described by American Society of Anesthesiologists Classification (ASA Class)
Time frame: Participants will be followed up during surgery, an estimated duration of 1 hour
Anaesthesiological risk will be measured by length of anesthesia
Time frame: Participants will be followed up during surgery, an estimated duration of 1 hour
Anaesthesiological risk will be measured by type of anaesthesia
Time frame: Participants will be followed up during surgery, an estimated duration of 1 hour
Intraoperative depth of sedation will be monitored with changes in the pattern and power spectrum of EEG-raw data measured with the Masimo SedLine® brain function monitoring for Root®, Narcotrend®, BIS™ and additionally quantified by indices [e.g. PSI or BIS-index] and burst suppression ratio.
Time frame: Participants will be followed for the duration of intensive care unit stay, an expected average of 5 days
Sedation is measured by Richmond Agitation Sedation Scale.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Sedation is measured by Richmond Agitation Sedation Scale.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Agitation describes a clinical state in which the patient may be impulsive and attempt to get out of bed, to wander, and to fall (which may lead to further injury or death) and attempt to remove IV lines, tubes, or catheters.
Time frame: Up to 5 days
Postoperative delirium rate, defined according to Diagnostic and Statistical Manual of Mental Disorders (DSM-V), CAM/CAM-ICU, Nu-DESC and Chart Review.
Time frame: Up to 5 days
Postoperative delirium rate, defined according to Confusion assessment method - severity(CAM-S); Delirium Rating Scale Revised (DSR-R-98), Intensive Care Delirium Screening Checklist (ICDSC) and Nursing Delirium Screening Scale (Nu-DESC).
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Duration of postoperative delirium, defined according to medical evaluation, measured in days
Time frame: Up to hospital discharge, an expected average of 5 days
Pain during hospital stay will be measured with the Numeric Rating Scale (NRS-V).
Time frame: Up to hospital discharge, an expected average of 5 days
For patients unable of pain self-assessment (e.g. ventilated patients, patients in delirious state or patients with stroke affecting language skills) observer-rated pain scales will be applied: Behavioural Pain Scale (BPS for ventilated) and BPS-NI (for non-ventilated) patients, Critical-Care Pain Observation Tool (CPOT) during hospital stay.
Time frame: Participants will be followed for the duration of intensive care unit stay, an expected average of 5 days
Intensive care unit length of stay describes every day spent in an ICU bed.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
Hospital length of stay describes every day spent in an hospital.
Time frame: Up to 5 days
Perioperative anxiety will be measured with APAIS preoperatively and the Faces Anxiety Scale (FAS) and during hospital stay.
Time frame: Up to 5 days
Stress is measured by Perceived Stress Questionnaire 20
Time frame: Up to 5 days
Stress level is measured by stress thermometer
Time frame: Up to 5 days
Anxiety will be measured with the Generalized Anxiety Disorder 7-Item Scale (GAD-7)
Time frame: Up to 5 years
Depression is measured by PHQ-8. Scores represent:0-5 = mild, 6-10 = moderate, 11-15 = moderately severe, 16-20 = severe depression
Time frame: Up to 5 years
Quality of sleep is measured by the Insomnia Severity Index.
Time frame: Up to hospital discharge, an expected average of 7 days
Time frame: Up to hospital discharge, an expected average of 7 days
Organ dysfunctions are evaluated according to the Clavien-Dindo classification of surgical complications
Time frame: Up to five years
Time frame: Up to 5 years
Prescribed regular drug intake from baseline at all follow ups including perioperative application of drugs, infusions and transfusions will be evaluated.
Time frame: Up to 5 years
Quality of life will be measured with the EQ-5D-5L
Time frame: Up to 5 years
Level of dependency will be measured with with ADL/IADL, single items concerning patients' living situation and the BSSS-17 (Berlin Social Support Scales).
Time frame: Up to 5 years
Variables affecting performance of cognitive testings
Time frame: Up to 5 years
Hospital readmission is an episode when a patient who had been discharged from a hospital is admitted again within a specified time interval.
Time frame: Up to 5 years
Surgery performed to replace or compensate for a failed implant or to correct undesirable sequelae of previous surgery.
Time frame: Up to 5 years
Treatment outside of the hospital in an associated facility for diagnosis or treatment.
Time frame: Up to 5 years
The number of deaths in a given period.
Time frame: Up to 5 years
Dementia reported as clinical diagnosis based on DSM-5 criteria for major NCD either through neuropsychological evaluation at a memory clinic or as a research diagnosis based on neuropsychological test values (CANTAB/MOCA), cognitive concern (MMQ/IQCODE) and functionality (ADL/IADL).
Time frame: Up to five years
The incongruence questionnaire (Der Inkongruenzfragebogen)
Time frame: Up to five years
Questionnaire on frequency of cognitively stimulating leisure activities
Time frame: Up to five years
Time frame: Up to five years
Time frame: Up to seven days
Spectral analysis with band power are measured by EEG at third postoperative day and delirium dependent until postoperative day 7.
Time frame: Up to three months
Pain is measured with dolosys paintracker
Time frame: Up to five years
Loneliness is measured with the UCLA-Loneliness-Scale (3 items)
Time frame: Up to five years
Social support is measured with the Berliner Social-Support Skalen BSSS-17
Time frame: Up to five years
Living situation is measured with te question: How do you live?
Time frame: At the beginning of the observation
Obesity is measured by body mass index (BMI)
Time frame: At the beginning of the observation
Obesity is measured by waist to hip ratio
Time frame: At the beginning of the observation
Reading / writing weakness, hendedness, native speaker
Time frame: At the beginning of the observation
Frailty will be measured by Fried's criteria (Physical Frailty Phenotype), Fried et al: Frailty in older adults: evidence for a phenotype. J.Gerontol.A Biol.Sci.Med.Sci. 2001; 56: M146-M156 and evaluated in a short comprehensive geriatric assessment as decribed by Birkelbach, O. et al. Warum und wie sollte ich Frailty erfassen? - ein Ansatz für die Anästhesieambulanz. Anasthesiol. Intensivmed. Notfallmedizin Schmerztherapie 52, 765-776 (2017).
Time frame: At the beginning of the observation
Level of education (years of formal training, last occupation, ISCED-2011 and crystalline intelligence [IQ-variable calculated with NART/MWT-A or other national equivalent ] will be used to evaluate cognitive reserve.
Time frame: At the beginning of the observation
Mehrfachwahl-Wortschatz-Intelligenztest (MWT-A) and National Adult Reading Test (NART)
Time frame: At the beginning of the observation
Interview guide employment situation and previous professional activity adapted to Engstler (2017); Classification according to ISCO 08; Workload indices according to Kroll (2011)
Time frame: At the beginning of the observation
Delusion proneness is measured by Peter's Delusion Inventory
Time frame: At the beginning of the observation
History of physical activity less than 30 minutes / day (i.e. moderate increase in heart rate due to fast walking, cycling or other exercise)
Time frame: At the beginning of the observation
Spectral analysis with band power are measured by EEG
Time frame: At the beginning of the observation
Preoperative Cognitive Impairment (PreCI) is measured by computerized and paper pencil tests
Charite University, Berlin, Germany
Other
Evaluation of POCD-Census Prospective, International Observation Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02096068
Confusion, Delirium
Berlin, Germany
View Trial DetailsNCT07302061
Postoperative Cognitive Deficit (POCD)
Istanbul, Kadikoy, Turkey (Türkiye)
View Trial DetailsNCT05318976
Alzheimer Disease, Brain Diseases
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT05866822
Mental Disorders, Neurocognitive Disorders
Nice, France
View Trial Details